Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Dolomite Centre Ltd.. (12/17/13). "Press Release: Dolomite Is Key Partner in Collaborative R&D Consortium". 2013-12-17
Crescendo Biologics Ltd.. (12/17/13). "Press Release: Crescendo Biologics Raises £17.5M ($28M) in Series A Financing". Cambridge. 2013-12-17
GlaxoSmithKline plc. (12/17/13). "Press Release: GSK Announces Changes to Its Global Sales and Marketing Practices to Further Ensure Patient Interests Come First". London. 2013-12-17
Heptares Therapeutics Ltd.. (12/16/13). "Press Release: Heptares Highlights Potential of STaR Proteins as Antigens for GPCR-targeted Antibody Discovery in New Scientific Publication". London & Boston, MA. 2013-12-16
Microsaic Systems plc. (12/11/13). "Press Release: Holding in Company". 2013-12-11
Ario Pharma Ltd.. (12/11/13). "Press Release: Ario Pharma Ltd Founded to Develop Novel Therapeutics for Respiratory Indications". Cambridge. 2013-12-11
Prothena Corporation plc. (12/11/13). "Press Release: Roche and Prothena Enter into Worldwide Collaboration to Co-develop and Co-promote Antibodies for Treatment of Parkinson’s Disease". Basel & Dublin. 2013-12-11
Adaptimmune Ltd.. (12/10/13). "Press Release: Adaptimmune Announces Interim Results from a Phase I/II Trial of Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma". Oxford & Philadelphia, PA. 2013-12-10
Heptares Therapeutics Ltd.. (12/9/13). "Press Release: Heptares Initiates Clinical Study with First Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients with Alzheimer’s Disease". London & Boston, MA. 2013-12-09
GlaxoSmithKline plc. (12/5/13). "Press Release: GSK Launches Global Consortium with Six Renowned Cancer Research Centres". London & Philadelphia, PA. 2013-12-05
Hiden Analytical Ltd.. (12/5/13). "Press Release: Multicapacity Microreactor for Catalyst Characterisation". 2013-12-05
Druggability Technologies Holdings Ltd.. (12/5/13). "Press Release: DRGT Enters into a Strategic Collaboration with Bayer HealthCare". Dublin & Budapest. 2013-12-05
Proteome Sciences plc. (12/4/13). "Press Release: Trading Update". 2013-12-04
AstraZeneca plc. (12/3/13). "Press Release: AstraZeneca and Lieber Institute for Brain Development Announce Neuroscience Collaboration". 2013-12-03
Titian Software Ltd.. (12/3/13). "Press Release: Titian’s Mosaic Sample Management Software Selected for the European Lead Factory Initiative". London. 2013-12-03
Oxford Immunotec Global plc. (12/2/13). "Press Release: Oxford Immunotec Global plc Announces Appointment of Herm Rosenman to the Board of Directors". Oxford & Marlborough, MA. 2013-12-02
Oxford Immunotec Global plc. (12/2/13). "Press Release: Oxford Immunotec Global plc Announces Closing of Initial Public Offering and Exercise of Over-allotment Option". Oxford & Marlborough, MA. 2013-12-02
Omega Diagnostics Group plc. (11/27/13). "Press Release: Interim Results for the Six Months Ended 30 September 2013". 2013-11-27
Waters Corporation. (11/27/13). "Press Release: Waters Teams with Biochemical Society on Proteomics Training Day and Symposium. Dates and Agenda Set, Registration Now Open for Quantitative Proteomics and ProteoMMX 3.0 Events". Milford, MA. 2013-11-27
Agalimmune Ltd.. (11/26/13). "Press Release: Agalimmune Ltd Founded to Develop Immunotherapeutics for Cancer". London & Worcester, MA. 2013-11-26
Almac Group Ltd.. (11/26/13). "Press Release: Genomic Health and Almac Group Enter Exclusive In-licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer". Redwood City, CA & Craigavon. 2013-11-26
Lab M Ltd.. (11/25/13). "Press Release: Lab M Appoints Director of Sales and Marketing as New Products Fuel Increased Sales". 2013-11-25
AstraZeneca plc. (11/22/13). "Press Release: Xigdua (dapagliflozin and metformin hydrochloride) Receives Positive CHMP Opinion in the European Union for the Treatment of Type 2 Diabetes". 2013-11-22
GlaxoSmithKline plc. (11/22/13). "Press Release: Tivicay (dolutegravir) Receives Positive CHMP Opinion in Europe for the Treatment of HIV". London. 2013-11-22
Oxford Immunotec Global plc. (11/22/13). "Press Release: Oxford Immunotec Global plc Announces Pricing of Initial Public Offering". Oxford & Marlborough, MA. 2013-11-22
Instem. (11/22/13). "Press Release: Instem Acquires Perceptive Instruments, Leader in Image Analysis and Data Management Solutions". Conshohocken, PA. 2013-11-22
Eagle Genomics Ltd.. (11/21/13). "Press Release: Eagle Genomics Completes £1m First Fundraising". Cambridge. 2013-11-21
Imperial Innovations Group plc. (11/20/13). "Press Release: Pulmocide Receives £17m Series A Funding". 2013-11-20
Galapagos N.V.. (11/20/13). "Press Release: Galapagos Announces that BioFocus Has Signed an Integrated Drug Discovery Collaboration with Boehringer Ingelheim". Mechelen. 2013-11-20
GlaxoSmithKline plc. (11/20/13). "Press Release: GSK and Amicus Therapeutics Announce Revised Fabry Agreement". London & Cranbury, NJ. 2013-11-20
Proteome Sciences plc. (11/20/13). "Press Release: Novel Patient Stratification Biomarkers for Liver Cancer". Berlin. 2013-11-20
Adaptimmune Ltd.. (11/20/13). "Press Release: Adaptimmune Appoints Dr Jonathan Knowles as Chairman of the Board". Oxford & Philadelphia, PA. 2013-11-20
General Electric Company. (11/19/13). "Press Release: GE Healthcare and Cellectis Agree to Sublicense for Stem Cell Patents". Chalfont St. Giles. 2013-11-19
Mission Therapeutics Ltd.. (11/18/13). "Press Release: Mission Secures £20m ($32m) Series B Financing". Cambridge, UK. 2013-11-18
InSphero AG. (11/18/13). "Press Release: Cambridge Bioscience Our New Distributor for the UK". 2013-11-18
GlaxoSmithKline plc. (11/18/13). "Press Release: Relvar Ellipta Receives European Marketing Authorisation for the Treatment of Asthma and COPD". London & South San Francisco, CA. 2013-11-18
Oxford Nanopore Technologies Ltd.. (11/15/13). "Press Release: Oxford Nanopore Announces Secondary Placing, Divestment of Illumina". 2013-11-15
Immunocore Ltd.. (11/14/13). "Press Release: Immunocore Appoints Dr Jonathan Knowles as Chairman of the Board". Oxford. 2013-11-14
Galapagos N.V.. (11/12/13). "Press Release: Galapagos Subsidiary BioFocus Signs Agreement with Biogen Idec in Sclerodoma. Identification and Validation of Novel Targets in Scleroderma". Mechelen. 2013-11-12
Shire plc. (11/11/13). "Press Release: Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio, Will Augment Already Strong Growth Prospects". 2013-11-11
Biotage AB. (11/11/13). "Press Release: Biotage Isolera Dalton Chromatography System Installed at Labstract". 2013-11-11
BBSRC. (11/8/13). "Press Release: Meet Professor Jackie Hunter, BBSRC’s New Chief Executive". 2013-11-08
AB Sciex. (11/8/13). "Press Release: AB Sciex’s European MASStastic Voyage Tour Brings Mobile Analytical Laboratory to Ireland’s Gathering of Leading Separation Scientists". Framingham, MA. 2013-11-08
Redx Pharma Ltd.. (11/7/13). "Press Release: Redx Agrees Pioneering MRSA Deal with NHS". 2013-11-07
Immunocore Ltd.. (11/7/13). "Press Release: Immunocore Achieves Research Milestone in GlaxoSmithKline Collaboration". Oxford. 2013-11-07
SpectralWorks Ltd.. (11/7/13). "Press Release: AnalyzerPro Goes to the Dogs – »Scentomics« to Protect Endangered African Wild Dogs". 2013-11-07
Microsaic Systems plc. (11/7/13). "Press Release: New Leasing Arrangement for 4000 MiD". 2013-11-07
BBSRC. (11/6/13). "Press Release: Synthetic Biology Enterprise Boost as New Fund Opens for Business". 2013-11-06
Abcam plc. (11/4/13). "Press Release: Abcam Introduces Alexa Fluor Secondary Antibodies. New Range Offers Increased Choice for Multi-colour Staining". Cambridge. 2013-11-04
Canbex Therapeutics Ltd.. (11/4/13). "Press Release: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis". London. 2013-11-04
AstraZeneca plc. (11/4/13). "Press Release: A*STAR and AstraZeneca Sign a Research Collaboration Agreement to Develop New Antimicrobial Drugs to Combat Gram-negative Bacterial Infections". 2013-11-04
Antisoma plc. (11/1/13). "Press Release: Result of AGM and Change of Name". Breda. 2013-11-01
AstraZeneca plc. (10/31/13). "Press Release: Marc Dunoyer Appointed Chief Financial Officer of AstraZeneca". 2013-10-31
Immunocore Ltd.. (10/31/13). "Press Release: Immunocore Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma". Oxford. 2013-10-31
Proteome Sciences plc. (10/30/13). "Press Release: Proteome Sciences Appoints Director of Personalised Medicine". 2013-10-30
Almac Group Ltd.. (10/29/13). "Press Release: Richard Segiel, Jr. Joins Almac as Vice President of US Business Development". 2013-10-29
GlaxoSmithKline plc. (10/25/13). "Press Release: ViiV Healthcare Announces European Regulatory Submission for a Single-tablet Regimen Combining Dolutegravir with Abacavir and Lamivudine for People Living with HIV". London. 2013-10-25
Cancer Research UK. (10/24/13). "Press Release: Cancer Imaging Centres Get £35 Million Boost". 2013-10-24
GlaxoSmithKline plc. (10/23/13). "Press Release: Results Announcement for the Third Quarter 2013. GSK Announces Q3 Core EPS Growth of 16% and Dividend of 19p". 2013-10-23
Almac. (10/22/13). "Press Release: Novozymes Biopharma Announces Collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies. Combined Service Offers Drug Development Companies Efficiencies in Time and Resource". 2013-10-22
AstraZeneca plc. (10/22/13). "Press Release: AstraZeneca Initiates Phase III Clinical Programme for Selumetinib, a Treatment in Development for Patients with Advanced or Metastatic Non-small Cell Lung Cancer". 2013-10-22
Ithaka Life Sciences Ltd.. (10/22/13). "Press Release: Ithaka Life Sciences Client CYP Design Ltd Completes Seed Funding Round". 2013-10-22
Peak Scientific Instruments Ltd.. (10/22/13). "Press Release: Peak Scientific Sign Formal OEM Agreement with Bruker’s Chemical and Applied Markets Division". 2013-10-22
Illumina, Inc.. (10/21/13). "Press Release: University of Cambridge, Genomics England Ltd., and Illumina Collaborate to Sequence 10,000 Whole Genome Sequence for National Health Service Patients. Project Will Lay Foundation for Genomic Medicine". Cambrid 2013-10-21
Microsaic Systems plc. (10/21/13). "Press Release: Microsaic Systems Announces Prestigious New Scientific Advisory Group. High Profile Group Members Drawn from Research and Industry". 2013-10-21
AstraZeneca plc. (10/17/13). "Press Release: AstraZeneca Announces »Open Innovation« Research Collaboration with Taiwan’s Research Program for Biopharmaceuticals". Taipei. 2013-10-17
Sygnature Discovery Ltd.. (10/17/13). "Press Release: Sygnature Discovery and Proteros Biostructures Establish Strategic Alliance". Nottingham & Munich. 2013-10-17
University of Manchester. (10/17/13). "Press Release: State-of-the-Art Research Equipment Thanks to Funding Boost". 2013-10-17
AstraZeneca plc. (10/16/13). "Press Release: Harvard’s Wyss Institute and AstraZeneca Announce Collaboration on Organs-on-Chips for Drug Discovery Safety Testing". Boston, MA. 2013-10-16
Sistemic Ltd.. (10/15/13). "Press Release: Sistemic and QCMD Announce an Innovative Collaboration Aimed at Addressing the Need for Quality Assurance and Standardisation in the Cell Therapy Field as the Industry Shows Signs of Maturing". 2013-10-15
Horizon Discovery Ltd.. (10/15/13). "Press Release: Horizon Discovery Receives Share of €5.75M ($7.8M) EU FP7 Grant". Cambridge. 2013-10-15
Crown Bioscience, Inc.. (10/14/13). "Press Release: Crown Bioscience Enhances Oncology Research Services with Targeted Beam Radiation Therapy via Business Collaboration with Xstrahl Ltd". Santa Clara, CA. 2013-10-14
AstraZeneca plc. (10/11/13). "Press Release: AstraZeneca Enters Co-promotion Agreement with Janssen in Japan for Innovative Prostate Cancer Treatment". 2013-10-11
IP Group plc. (10/10/13). "Press Release: IP Group plc Completes £5m Investment in Cambridge Innovation Capital – Signs MoU to Facilitate Access to Co-investment Opportunities". 2013-10-10
Cambridge Enterprise. (10/10/13). "Press Release: £50 Million of New Funding to Support Cambridge Companies". 2013-10-10
Heptares Therapeutics Ltd.. (10/10/13). "Press Release: Heptares Delivers First Stabilised GPCR (STaR) to MorphoSys for Antibody Discovery". Welwyn Garden City & Boston, MA. 2013-10-10
Oxford Nanopore Technologies Ltd.. (10/9/13). "Press Release: Oxford Nanopore Announces £40 Million ($64 Million) Fundraising". 2013-10-09
Fujifilm Diosynth Biotechnologies UK Ltd.. (10/9/13). "Press Release: Fujifilm Diosynth Biotechnologies’ UK Site Receives Renewed MHRA Manufacturing Licence". Billingham & Norrisville, NC. 2013-10-09
Horizon Discovery Ltd.. (10/8/13). "Press Release: Horizon Discovery and Blueprint Medicines Enter Oncology Research Service Agreement. Horizon Will Support and Guide New Targets Discovery". Cambridge. 2013-10-08
Almac. (10/7/13). "Press Release: Almac Launches New [14C]-labelled ADCs Service Offering". 2013-10-07
Fujifilm Diosynth Biotechnologies UK Ltd.. (10/2/13). "Press Release: Fujifilm Diosynth Biotechnologies Opens New Manufacturing Facility". Billingham, Teesside. 2013-10-02
AstraZeneca plc. (10/1/13). "Press Release: AstraZeneca Welcomes New Arrivals as Alderley Park BioHub Expands". 2013-10-01
Activiomics Ltd.. (9/30/13). "Press Release: Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO". London. 2013-09-30
Malvern Instruments Ltd.. (9/30/13). "Press Release: Malvern Instruments Acquires Nanoparticle Characterization Company NanoSight". 2013-09-30
Microsaic Systems plc. (9/27/13). "Press Release: Interim Results for the Six Months Ended 30 June 2013". 2013-09-27
Dotmatics Ltd.. (9/24/13). "Press Release: Dotmatics Unveils Connection between Thomson Reuters’ Cortellis and Vortex. Dotmatics’ Vortex Provides a Means to Search, Visualize and Analye Thomson Reuters’ Cortellis Database". Bishops Stortford. 2013-09-24
BioOutsource Ltd.. (9/20/13). "Press Release: BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization and Comparability Testing". Boston, MA & Glasgow. 2013-09-20
BioFocus. (9/19/13). "Press Release: Activiomics Extends Research Agreement with Kyowa Hakko Kirin as Part of Its Strategic Partnership with BioFocus". 2013-09-19
Linguamatics Ltd.. (9/19/13). "Press Release: Linguamatics Enhances Access to Content with Latest Release of Text Mining Platform". Cambridge & Boston, MA. 2013-09-19
Abcodia Ltd.. (9/18/13). "Press Release: Abcodia Licenses the »Risk of Ovarian Cancer Algorithm« (ROCA) from Massachusetts General Hospital and Queen Mary, University of London". 2013-09-18
EpimiRNA Consortium. (9/18/13). "Press Release: EpimiRNA Consortium Receives €11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy". 2013-09-18
Ubiquigent Ltd.. (9/18/13). "Press Release: Ubiquigent Announces £0.5M Funding and Strenghtens Board of Directors with Key Appointment". Dundee. 2013-09-18
XO1 Ltd.. (9/17/13). "Press Release: Global Thought-leaders in Anticoagulation Join X01 Scientific Advisory Board, Richard Mason Appointed CEO". Cambridge. 2013-09-17
EMA (European Medicines Agency). (9/16/13). "Press Release: European Medicines Agency Reveals New Structure". 2013-09-16
Horizon Discovery Ltd.. (9/16/13). "Press Release: Horizon Discovery Licenses CRISPR Gene Editing Technology from Harvard University. Gene Editing Platform Now Includes rAAV, ZFN and CRISPR". Cambridge. 2013-09-16
Midatech Ltd.. (9/16/13). "Press Release: Midatech Appoints Dr Jim Phillips as Chief Executive Officer". 2013-09-16
Molecular Profiles Ltd.. (9/12/13). "Press Release: Columbia Laboratories Acquires Molecular Profiles Ltd.". Boston, MA & Nottingham. 2013-09-12
Quay Pharma. (9/12/13). "Press Release: Michael Kruidenier Joins Quay as European Business Development Manager". 2013-09-12
Egalet Ltd.. (9/12/13). "Press Release: Egalet Announces Financing to Fund Abuse-deterrent Medications. Two Lead Programs to Enter Pivotal Trials". Malvern, PA. 2013-09-12
AstraZeneca plc. (9/11/13). "Press Release: AstraZeneca and Merck Enter Licence Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer". 2013-09-11
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top